Regional distribution and kinetics of [18F]fluciclovine (anti-[18F]FACBC), a tracer of amino acid transport, in subjects with primary prostate cancer
Authors:
- 4 December 2012
- journal article
- research article
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 40 (3) , 394-402
Abstract
[18F]Fluciclovine (anti-[18F]FACBC) is a synthetic amino acid developed for PET assessment of the anabolic component of tumour metabolism in clinical routine. This phase 1 trial evaluated the safety, tracer stability and uptake kinetics of [18F]fluciclovine in patients.Keywords
This publication has 26 references indexed in Scilit:
- C11-Acetate and F-18 FDG PET for Men With Prostate Cancer Bone MetastasesClinical Nuclear Medicine, 2011
- Prognostic Value of Baseline [18F] Fluorodeoxyglucose Positron Emission Tomography and 99mTc-MDP Bone Scan in Progressing Metastatic Prostate CancerClinical Cancer Research, 2010
- Molecular imaging of prostate cancer with 18F-fluorodeoxyglucose PETNature Reviews Urology, 2009
- l‐type amino acid transporter 1 and CD98 expression in primary and metastatic sites of human neoplasmsCancer Science, 2008
- Novel Tracers and Their Development for the Imaging of Metastatic Prostate CancerJournal of Nuclear Medicine, 2008
- Prognostic Value of Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography Imaging in Patients With Advanced-Stage Non–Small-Cell Lung CarcinomaJournal of Clinical Oncology, 2008
- 1-11C-Acetate Kinetics of Prostate CancerJournal of Nuclear Medicine, 2008
- 11C-Acetate Positron Emission Tomography Imaging and Image Fusion With Computed Tomography and Magnetic Resonance Imaging in Patients With Recurrent Prostate CancerJournal of Clinical Oncology, 2006
- Analysis of Emission Tomographic Scan Data: Limitations Imposed by Resolution and BackgroundJournal of Computer Assisted Tomography, 1984
- A new look at the statistical model identificationIEEE Transactions on Automatic Control, 1974